OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Mitochondrial-Targeted Therapy for Doxorubicin-Induced Cardiotoxicity
Bin Bin Wu, Kam Tong Leung, Ellen Poon
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1912-1912
Open Access | Times Cited: 112
Bin Bin Wu, Kam Tong Leung, Ellen Poon
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1912-1912
Open Access | Times Cited: 112
Showing 1-25 of 112 citing articles:
Mitochondrial quality control mechanisms as therapeutic targets in doxorubicin-induced cardiotoxicity
Lin Wu, Litao Wang, Yuxin Du, et al.
Trends in Pharmacological Sciences (2022) Vol. 44, Iss. 1, pp. 34-49
Closed Access | Times Cited: 127
Lin Wu, Litao Wang, Yuxin Du, et al.
Trends in Pharmacological Sciences (2022) Vol. 44, Iss. 1, pp. 34-49
Closed Access | Times Cited: 127
The mechanism of ferroptosis and its related diseases
Shijian Feng, Dan Tang, Yichang Wang, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 56
Shijian Feng, Dan Tang, Yichang Wang, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 56
Chemotherapeutic and targeted drugs-induced immunogenic cell death in cancer models and antitumor therapy: An update review
Jiaqi Zhai, Xi Gu, Yang Liu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 54
Jiaqi Zhai, Xi Gu, Yang Liu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 54
Application of artificial intelligence and machine learning in early detection of adverse drug reactions (ADRs) and drug-induced toxicity
Siyun Yang, Supratik Kar
Artificial Intelligence Chemistry (2023) Vol. 1, Iss. 2, pp. 100011-100011
Open Access | Times Cited: 43
Siyun Yang, Supratik Kar
Artificial Intelligence Chemistry (2023) Vol. 1, Iss. 2, pp. 100011-100011
Open Access | Times Cited: 43
Rnd3 protects against doxorubicin-induced cardiotoxicity through inhibition of PANoptosis in a Rock1/Drp1/mitochondrial fission-dependent manner
Ge Wen, Xiaohua Zhang, Jie Lin, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Ge Wen, Xiaohua Zhang, Jie Lin, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Nrf2: a dark horse in doxorubicin-induced cardiotoxicity
Xiaopeng Zhao, Zheng Tian, Mingli Sun, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 35
Xiaopeng Zhao, Zheng Tian, Mingli Sun, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 35
Hydropersulfides (RSSH) attenuate doxorubicin-induced cardiotoxicity while boosting its anticancer action
Blaze M. Pharoah, Chengximeng Zhang, Vinayak S. Khodade, et al.
Redox Biology (2023) Vol. 60, pp. 102625-102625
Open Access | Times Cited: 25
Blaze M. Pharoah, Chengximeng Zhang, Vinayak S. Khodade, et al.
Redox Biology (2023) Vol. 60, pp. 102625-102625
Open Access | Times Cited: 25
Hydrogen sulfide alleviates mitochondrial damage and ferroptosis by regulating OPA3–NFS1 axis in doxorubicin-induced cardiotoxicity
Yifan Wang, Xiaoying Ying, Yuehong Wang, et al.
Cellular Signalling (2023) Vol. 107, pp. 110655-110655
Closed Access | Times Cited: 25
Yifan Wang, Xiaoying Ying, Yuehong Wang, et al.
Cellular Signalling (2023) Vol. 107, pp. 110655-110655
Closed Access | Times Cited: 25
Carnosic acid protects against doxorubicin-induced cardiotoxicity through enhancing the Nrf2/HO-1 pathway
Shan Hu, Beilei Liu, Manqi Yang, et al.
Food & Function (2023) Vol. 14, Iss. 8, pp. 3849-3862
Closed Access | Times Cited: 24
Shan Hu, Beilei Liu, Manqi Yang, et al.
Food & Function (2023) Vol. 14, Iss. 8, pp. 3849-3862
Closed Access | Times Cited: 24
DOXORUBICIN-RELATED CARDIOTOXICITY: REVIEW OF FUNDAMENTAL PATHWAYS OF CARDIOVASCULAR SYSTEM INJURY
Ashot Avagimyan, Nana Pogosova, L. V. Kakturskiy, et al.
Cardiovascular Pathology (2024) Vol. 73, pp. 107683-107683
Closed Access | Times Cited: 9
Ashot Avagimyan, Nana Pogosova, L. V. Kakturskiy, et al.
Cardiovascular Pathology (2024) Vol. 73, pp. 107683-107683
Closed Access | Times Cited: 9
Uncovering the Cardioprotective Potential of Diacerein in Doxorubicin Cardiotoxicity: Mitigating Ferritinophagy-Mediated Ferroptosis via Upregulating NRF2/SLC7A11/GPX4 Axis
Rehab M El-Gohary, Asmaa H. Okasha, Alaa H. Abd El-Azeem, et al.
Antioxidants (2024) Vol. 13, Iss. 4, pp. 493-493
Open Access | Times Cited: 7
Rehab M El-Gohary, Asmaa H. Okasha, Alaa H. Abd El-Azeem, et al.
Antioxidants (2024) Vol. 13, Iss. 4, pp. 493-493
Open Access | Times Cited: 7
Cardiotoxicity of Anticancer Drugs: Molecular Mechanisms, Clinical Management and Innovative Treatment
Feiyu Gao, Tao Xu, F Zang, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 4089-4116
Open Access | Times Cited: 7
Feiyu Gao, Tao Xu, F Zang, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 4089-4116
Open Access | Times Cited: 7
Molecular mechanisms of endothelial remodeling under doxorubicin treatment
Ekaterina Podyacheva, Maria Danilchuk, Yana Toropova
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114576-114576
Open Access | Times Cited: 18
Ekaterina Podyacheva, Maria Danilchuk, Yana Toropova
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114576-114576
Open Access | Times Cited: 18
Amentoflavone mitigates doxorubicin-induced cardiotoxicity by suppressing cardiomyocyte pyroptosis and inflammation through inhibition of the STING/NLRP3 signalling pathway
G. Fang, Xiuchuan Li, Fengyuan Yang, et al.
Phytomedicine (2023) Vol. 117, pp. 154922-154922
Closed Access | Times Cited: 18
G. Fang, Xiuchuan Li, Fengyuan Yang, et al.
Phytomedicine (2023) Vol. 117, pp. 154922-154922
Closed Access | Times Cited: 18
MicroRNA in the Diagnosis and Treatment of Doxorubicin-Induced Cardiotoxicity
Ziyu Kuang, Jingyuan Wu, Ying Tan, et al.
Biomolecules (2023) Vol. 13, Iss. 3, pp. 568-568
Open Access | Times Cited: 16
Ziyu Kuang, Jingyuan Wu, Ying Tan, et al.
Biomolecules (2023) Vol. 13, Iss. 3, pp. 568-568
Open Access | Times Cited: 16
Recent Advances in Mitochondrial Fission/Fusion-Targeted Therapy in Doxorubicin-Induced Cardiotoxicity
Chayodom Maneechote, Siriporn C. Chattipakorn, Nipon Chattipakorn
Pharmaceutics (2023) Vol. 15, Iss. 4, pp. 1182-1182
Open Access | Times Cited: 16
Chayodom Maneechote, Siriporn C. Chattipakorn, Nipon Chattipakorn
Pharmaceutics (2023) Vol. 15, Iss. 4, pp. 1182-1182
Open Access | Times Cited: 16
The m6A demethylase fat mass and obesity-associated protein mitigates pyroptosis and inflammation in doxorubicin-induced heart failure via the toll-like receptor 4/NF-κB pathway
Weiling Tu, Xiao Huang, Song‐Tao Liu, et al.
Cardiovascular Diagnosis and Therapy (2024) Vol. 14, Iss. 1, pp. 158-173
Open Access | Times Cited: 6
Weiling Tu, Xiao Huang, Song‐Tao Liu, et al.
Cardiovascular Diagnosis and Therapy (2024) Vol. 14, Iss. 1, pp. 158-173
Open Access | Times Cited: 6
Aucubin alleviates doxorubicin-induced cardiotoxicity through crosstalk between NRF2 and HIPK2 mediating autophagy and apoptosis
Weili Li, Jing Cao, Yawen Zhang, et al.
Phytomedicine (2024) Vol. 127, pp. 155473-155473
Closed Access | Times Cited: 5
Weili Li, Jing Cao, Yawen Zhang, et al.
Phytomedicine (2024) Vol. 127, pp. 155473-155473
Closed Access | Times Cited: 5
The mechanism and therapeutic strategies in Doxorubicin induced cardiotoxicity: Role of programmed cell death
Yanzhao Li, Jing Yan, Pingzhen Yang
Cell Stress and Chaperones (2024)
Open Access | Times Cited: 5
Yanzhao Li, Jing Yan, Pingzhen Yang
Cell Stress and Chaperones (2024)
Open Access | Times Cited: 5
Glucagon-like peptide-1(GLP-1) Prevents Doxorubicin-Induced Cardiotoxicity by Regulating Macrophage Polarization
Lujin Wu, Yating Qin, Xi-Long Zheng, et al.
Research Square (Research Square) (2025)
Closed Access
Lujin Wu, Yating Qin, Xi-Long Zheng, et al.
Research Square (Research Square) (2025)
Closed Access
GV1001, hTERT Peptide Fragment, Prevents Doxorubicin-Induced Endothelial-to-Mesenchymal Transition in Human Endothelial Cells and Atherosclerosis in Mice
Wei Chen, Seo‐Jin Kim, Sharon Kim, et al.
Cells (2025) Vol. 14, Iss. 2, pp. 98-98
Open Access
Wei Chen, Seo‐Jin Kim, Sharon Kim, et al.
Cells (2025) Vol. 14, Iss. 2, pp. 98-98
Open Access
Doxorubicin or Epirubicin Versus Liposomal Doxorubicin Therapy—Differences in Cardiotoxicity
Barbara Buchalska, Katarzyna Kamińska, Michał Kowara, et al.
Cardiovascular Toxicology (2025)
Closed Access
Barbara Buchalska, Katarzyna Kamińska, Michał Kowara, et al.
Cardiovascular Toxicology (2025)
Closed Access
Cuproptosis Cell Death Molecular Events and Pathways to Liver Disease
Yun Mao, Huilan Chen, Weihan Zhu, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 883-894
Open Access
Yun Mao, Huilan Chen, Weihan Zhu, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 883-894
Open Access
Edaravone is a Therapeutic Candidate for Doxorubicin‐Induced Cardiomyopathy by Activating the Nrf2 Pathway
Naoki Yoshikawa, Naoto Hirata, Yuichiro Kurone, et al.
Pharmacology Research & Perspectives (2025) Vol. 13, Iss. 1
Open Access
Naoki Yoshikawa, Naoto Hirata, Yuichiro Kurone, et al.
Pharmacology Research & Perspectives (2025) Vol. 13, Iss. 1
Open Access
Dexmedetomidine Inhibits Ferroptosis Through the Akt/Gsk3β/Nrf2 Axis and Alleviates Adriamycin -Induced Cardiotoxicity
Xuefeng Cao, Liang Zhao, Jian Zhou, et al.
(2025)
Closed Access
Xuefeng Cao, Liang Zhao, Jian Zhou, et al.
(2025)
Closed Access
